Safety of a New Security Device in Patients With Implanted Cardiac Electronic Devices
Not Applicable
Completed
- Conditions
- Electromagnetic Interference
- Registration Number
- NCT03264222
- Lead Sponsor
- Deutsches Herzzentrum Muenchen
- Brief Summary
Patients with implantable cardiac electronic devices will be exposed to a new safety device and evaluated for potential electromagnetic interference.
- Detailed Description
Patients with implanted pacemakers or defibrillators will undergo a screening procedure with an innovative security device. Evaluation will be made with respect to the occurrence of interference.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 379
Inclusion Criteria
- implantable pacemaker or defibrillator in situ
Exclusion Criteria
- malfunction of implantable pacemaker or defibrillator
- low battery voltage of implanted cardiac electronic device
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Electromagnetic interference 10 minutes Occurrence of electromagnetic interference
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms cause electromagnetic interference in cardiac electronic devices during security screening procedures?
How does the new security device compare to standard-of-care screening methods in terms of electromagnetic interference risk for pacemaker patients?
Are there specific biomarkers that predict susceptibility to electromagnetic interference in individuals with implanted defibrillators?
What adverse events have been reported in prior studies involving electromagnetic interference with cardiac implants and how are they managed?
What are the implications of NCT03264222 findings on the development of security screening technologies for patients with cardiac electronic devices?
Trial Locations
- Locations (1)
Deutsches Herzzentrum München
🇩🇪Munich, Bavaria, Germany
Deutsches Herzzentrum München🇩🇪Munich, Bavaria, Germany